Lipopolysaccharide-producing bacteria, lipopolysaccharides, and lipopolysaccharide-containing, medicines and veterinary medicines

摘要

Novel LPS having the following physical properties, novel bacilli providing those LPS, and novel immunity stimulators, anagesics, and antiwithdrawal agents, and novel veterinary immunity stimulators, analgesics, and antiwithdrawal agents containing LPS selected from the group consisting of those LPSs and mixtures thereof.PP LPS1 Dominant molecular weight: 5,000.+-.1,000 as determined byP P______________________________________ PP SDS- PAGE method PP______________________________________ PPPhosphorus number: PP 2 .+-. 1/5,000 (m.w.) PPHexosamine number: PP 9 .+-. 1/5,000 (m. w.) PPKDO number: 2 .+-. 1/5,000 (m.w.) P P ______________________________________ PPP PLPS2 Dominant molecular weight: 6,500.+-.2,500 as determined by______________________________________ SDS-PAGE method______________________________________Phosphorus number: 1 to 2/5, 000 (m.w.)Hexosamine number: 7 .+-. 1/5,000 (m.w.)KDO number: 1 to 2/5, 000 (m.w.)______________________________________ LPS3 Dominant molecular weight: 6,500.+-.2,500 as determined by______________________________________ SDS-PAGE method______________________________________Phosphorus number: 2 .+-. 1/5, 000 (m.w.)Hexosamine number: 5 .+-. 1/5,000 (m.w.)KDO number: 2 .+-. 1/5, 000 (m.w.)______________________________________